The MRC/BHF Heart Protection Study: preliminary results.

The MRC/BHF Heart Protection Study: preliminary results.

The Heart Protection Study (HPS), with over 20,500 subjects, is the largest trial of statin therapy ever conducted. It provides important and definitive new information on women, the elderly, diabetics, and people with low baseline cholesterol pre-treatment and those with prior occlusive non-coronar...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Collins, R, Peto, R, Armitage, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	2002

Documenti analoghi

MRC/BHF Heart Protection Study - Reply
di: Collins, R, et al.
Pubblicazione: (2002)

Comments on the MRC/BHF Heart Protection Study - Authors' reply
di: Collins, R, et al.
Pubblicazione: (2003)

MRC/BHF Heart Protection Study.
di: Vaughan, C, et al.
Pubblicazione: (2002)

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
di: Parish, S, et al.
Pubblicazione: (2012)

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
di: Collins, R, et al.
Pubblicazione: (2003)

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
di: Collins, R, et al.
Pubblicazione: (2002)

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
di: Emberson, J, et al.
Pubblicazione: (2005)

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
di: Armitage, J, et al.
Pubblicazione: (2000)

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
di: Emberson, J, et al.
Pubblicazione: (2005)

MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS
di: Bulbulia, R, et al.
Pubblicazione: (2007)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
di: Emberson, JR, et al.
Pubblicazione: (2007)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
di: Heart Protection Study Collaborative Group
Pubblicazione: (2002)

Heart Protection Study - Reply
di: Collins, R, et al.
Pubblicazione: (2003)

New analyses of Heart Protection Study - Reply
di: Collins, R, et al.
Pubblicazione: (2004)

Assessing the impact sensitivity of explosives using the BHF-12A equipment
di: Rădeanu Cristian, et al.
Pubblicazione: (2020-01-01)

The MRC spine stabilization trial
di: Wilson-MacDonald, J, et al.
Pubblicazione: (2008)

Failure Investigation of Blank Holder Force (BHF) Control in The Outside Bracket For Front Seat
di: Rofan Yulian Romansyah, et al.
Pubblicazione: (2023-06-01)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
di: Kinsey, S, et al.
Pubblicazione: (2002)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
di: J. M. Short, et al.
Pubblicazione: (2023-09-01)

MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
di: Meade, T, et al.
Pubblicazione: (1999)

HYPERFINE INTERACTIONS, INCLUDING BHF[FRFE], STUDIED IN THE DECAY CHAIN OF RA-225 BY ALPHA-ANISOTROPY AND GAMMA-ANISOTROPY MEASUREMENTS
di: Lindroos, M, et al.
Pubblicazione: (1992)

The MRC British Genetics of Hypertension Study - Genome-wide screen results
di: Caulfield, M, et al.
Pubblicazione: (2002)

C-reactive protein in the Heart Protection Study - Authors' reply
di: Emberson, J, et al.
Pubblicazione: (2011)

Progress with interferon in CML--results of the MRC UK CML III study.
di: Shepherd, P, et al.
Pubblicazione: (1996)

C-reactive protein in the Heart Protection Study Reply
di: Emberson, J, et al.
Pubblicazione: (2011)

Economic evaluation of the Heart Protection Study
di: Briggs, A, et al.
Pubblicazione: (2003)

Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study
di: Hopewell, J, et al.
Pubblicazione: (2011)

Biotransformations of (-)-Nopol by Aspergillus terreus MRC 200365 and Aspergillus fumigatus MRC 200358
di: Semra Yılmazer Keskin, et al.
Pubblicazione: (2010-06-01)

Consumer involvement at the MRC Clinical Trials Unit: results of a survey
di: Vale Claire L, et al.
Pubblicazione: (2011-12-01)

No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
di: Hopewell, J, et al.
Pubblicazione: (2009)

Biotransformations of ;#946;-Ionone by Aspergillus tamarii MRC 72400 and Aspergillus terreus MRC 200365
di: Semra Yılmazer Keskin, et al.
Pubblicazione: (2010-06-01)

INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL
di: Allan, N, et al.
Pubblicazione: (1994)

Cohort differences in disease and disability in the young-old: findings from the MRC Cognitive Function and Ageing Study (MRC-CFAS)
di: Paykel Eugene S, et al.
Pubblicazione: (2007-07-01)

No support for linkage of chromosome 17(q21-24) to Essential Hypertension in the MRC British Genetics of Hypertension (MRC BRIGHT) Study.
di: Knight, J, et al.
Pubblicazione: (2001)

ANXIETY, FRACTURE RISK AND ADHERENCE TO TREATMENT: THE MRC SCOOP TRIAL
di: Harvey, N, et al.
Pubblicazione: (2012)

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
di: Maughan, T, et al.
Pubblicazione: (2010)

The MRC spine stabilization trial: surgical methods, outcomes, costs, and complications of surgical stabilization.
di: Wilson-MacDonald, J, et al.
Pubblicazione: (2008)

Lipoprotein(a) Genetic Variants Associated With Risk of Atherothrombotic Disease in 14,465 Participants From the Heart Protection Study
di: Hopewell, J, et al.
Pubblicazione: (2010)

RETRACTED: Rainbow trout MRC structures
di: Golotin Vasily, et al.
Pubblicazione: (2024-01-01)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease
di: Collins, R, et al.
Pubblicazione: (2002)